Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Bellmann-Strobl

Showing results (141-150 of 173) with videos related to

Pageof 18
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 21, 2025
Investigating the impact of age on neurodegeneration after optic neuritis in multiple sclerosis using optical coherence tomographyHenriette Km Reinsberg, Frederike C Oertel, Daniel Casillas, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 25, 2021
Epigallocatechin Gallate in Relapsing-Remitting Multiple Sclerosis: A Randomized, Placebo-Controlled TrialJudith Bellmann-Strobl, Friedemann Paul, Jens Wuerfel, et al.
Journal of Neurology|December 4, 2025
Anchor-based evaluation of digital motor biomarkers from a 2-year observation in 100 patients with multiple sclerosisCarla A Ellinghaus, Hanna M Röhling, Eva-Maria Dorsch, et al.
European Journal of Neurology|January 10, 2021
Pain, depression, and quality of life in adults with MOG-antibody-associated diseaseSusanna Asseyer, Eugenia Henke, Corinna Trebst, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 21, 2020
Anti-MOG antibody-associated disorders: differences in clinical profiles and prognosis in Japan and GermanyJia Liu, Masahiro Mori, Hanna Zimmermann, et al.
Journal of Neurology|April 6, 2023
Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosisSven Jarius, Orhan Aktas, Ilya Ayzenberg, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 6, 2023
Visually Evoked Potential as Prognostic Biomarker for Neuroaxonal Damage in Multiple Sclerosis From a Multicenter Longitudinal CohortFrederike Cosima Oertel, Julia Krämer, Seyedamirhosein Motamedi, et al.
Journal of Neurology|April 5, 2024
Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term managementTania Kümpfel, Katrin Giglhuber, Orhan Aktas, et al.
Journal of Neurology|September 7, 2023
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term managementTania Kümpfel, Katrin Giglhuber, Orhan Aktas, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 14, 2022
SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimodLil Meyer-Arndt, Julian Braun, Florent Fauchere, et al.
Pageof 18

Showing results (141-150 of 173) with videos related to

Sort By:
Pageof 18
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 21, 2025
Investigating the impact of age on neurodegeneration after optic neuritis in multiple sclerosis using optical coherence tomographyHenriette Km Reinsberg, Frederike C Oertel, Daniel Casillas, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 25, 2021
Epigallocatechin Gallate in Relapsing-Remitting Multiple Sclerosis: A Randomized, Placebo-Controlled TrialJudith Bellmann-Strobl, Friedemann Paul, Jens Wuerfel, et al.
Journal of Neurology|December 4, 2025
Anchor-based evaluation of digital motor biomarkers from a 2-year observation in 100 patients with multiple sclerosisCarla A Ellinghaus, Hanna M Röhling, Eva-Maria Dorsch, et al.
European Journal of Neurology|January 10, 2021
Pain, depression, and quality of life in adults with MOG-antibody-associated diseaseSusanna Asseyer, Eugenia Henke, Corinna Trebst, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 21, 2020
Anti-MOG antibody-associated disorders: differences in clinical profiles and prognosis in Japan and GermanyJia Liu, Masahiro Mori, Hanna Zimmermann, et al.
Journal of Neurology|April 6, 2023
Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosisSven Jarius, Orhan Aktas, Ilya Ayzenberg, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 6, 2023
Visually Evoked Potential as Prognostic Biomarker for Neuroaxonal Damage in Multiple Sclerosis From a Multicenter Longitudinal CohortFrederike Cosima Oertel, Julia Krämer, Seyedamirhosein Motamedi, et al.
Journal of Neurology|April 5, 2024
Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term managementTania Kümpfel, Katrin Giglhuber, Orhan Aktas, et al.
Journal of Neurology|September 7, 2023
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term managementTania Kümpfel, Katrin Giglhuber, Orhan Aktas, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 14, 2022
SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimodLil Meyer-Arndt, Julian Braun, Florent Fauchere, et al.
Pageof 18